MARKET

ARWR

ARWR

Arrowhead Pharma
NASDAQ
49.36
+0.36
+0.73%
After Hours: 49.07 -0.29 -0.59% 17:02 11/11 EST
OPEN
49.65
PREV CLOSE
49.00
HIGH
49.74
LOW
47.66
VOLUME
2.53M
TURNOVER
--
52 WEEK HIGH
95.49
52 WEEK LOW
37.06
MARKET CAP
6.97B
P/E (TTM)
-22.0328
1D
5D
1M
3M
1Y
5Y
1D
Analysts Are Bullish on Top Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR), Kura Oncology (KURA)
TipRanks · 11h ago
Crispr Therapeutics: The Recent 40% Drop In Short Interest Indicates Deteriorating Bearish Sentiment
Seeking Alpha · 1d ago
PepGen Stock Spikes 132% on Rare-Disease Win. These Rivals Are Feeling The Pressure.
Barron‘s · 1d ago
Analysts Offer Insights on Healthcare Companies: Crispr Therapeutics AG (CRSP) and Arrowhead Pharmaceuticals (ARWR)
TipRanks · 1d ago
Piper Sandler Reaffirms Their Buy Rating on Arrowhead Pharmaceuticals (ARWR)
TipRanks · 1d ago
Arrowhead Pharmaceuticals Becomes Oversold (ARWR)
NASDAQ · 2d ago
What Do Arrowhead Pharmaceuticals (ARWR) New AHA Trial Results Change?
Simply Wall St · 2d ago
Nasdaq 100 Jumps 3% as Chips Rebound; Nvidia Lags Most Since DeepSeek: Stock Market Today
Benzinga · 2d ago
More
About ARWR
Arrowhead Pharmaceuticals, Inc. develops medicines that treat intractable diseases by silencing the genes that cause them. The Company's therapies, using a broad portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, trigger the RNA interference (RNAi) mechanism to induce rapid, deep and durable knockdown of target genes. Its Targeted RNAi Molecule (TRiMTM) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting while being structurally simple. It is focused on various therapeutic areas, such as cardiometabolic, pulmonary, liver, neuromuscular and others. It has over 18 discovered drug candidates in clinical trials ranging from early stage (Phase I) to late stage (Phase III). The Company's pipeline products include plozasiran, zodasiran, olpasiran, ARO-RAGE, SRP-1002, GSK4532990, fazirsiran, daplusiran/tomligisiran, ARO-CFB, ARO-INHBE, ARO-C3, ARO-PNPLA3, SRP-1001 (ARO-DUX4), SRP-1003 (ARO-DM1), SRP-1004 (ARO-ATXN2), and others.

Webull offers Arrowhead Pharmaceuticals Inc stock information, including NASDAQ: ARWR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARWR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ARWR stock methods without spending real money on the virtual paper trading platform.